Granulocyte-macrophage colony-stimulating factor:an immunotarget for sepsis and COVID-19

作     者：Xiuying Mu Kai Liu Huajie Li Fu-Sheng Wang Ruonan Xu 

作者机构：Peking University 302 Clinical Medical SchoolBeijingChina Department of Infectious DiseasesFifth Medical Center of Chinese PLA General HospitalNational Clinical Research Center for Infectious DiseasesBeijingChina 

出 版 物：《Cellular & Molecular Immunology》 (中国免疫学杂志（英文版）)

年 卷 期：2021年第18卷第8期

页      面：2057-2058页

核心收录：

学科分类：1001[医学-基础医学(可授医学、理学学位)] 100102[医学-免疫学] 10[医学] 

基　　金：We acknowledge funding support from the National Natural Innovation Fund(Project 81721002) 

主　　题：stimulating macrophage lymphocytes 

摘      要：Granulocyte-macrophage colony-stimulating factor(GM-CSF),which belongs to the colony-stimulating factor(CSF)superfamily and was originally identified as a hemopoietic growth factor,is mainly produced by lymphocytes and innate lymphoid *** cell populations such as fibroblasts,endothelial cells,and epithelial cells may also secrete GM-CSF in response to an activating stimulus.